Initial data from the first phase 1 trial of the bispecific antibody FS222 demonstrate that it is a drug with a manageable safety profile and promising antitumour activity, especially in patients with...
Read moreInitial data from the IGNYTE clinical trial demonstrate that the combination of the oncolytic virus RP1 and nivolumab (PD-1 immune checkpoint inhibitor) provides durable and clinically significant ant...
Read moreUn estudio colaborativo supone la primera caracterización genética de pacientes con MM de alto riesgo tratados con un esquema terapéutico intensivo, en el que se describe una posible relación entr...
Read moreIt has been demonstrated that first-line treatment with 177LU-DOTATATE combined with long-acting octreotide significantly improves progression-free survival (PFS) in patients with recently diagnosed s...
Read morePeople with more complications and a worse prognosis continue to have dysbiosis, a change in the bacterial microbiota, one year after the operation. In contrast, people with a more positive post-surge...
Read moreData from the first two cohorts demonstrated that combination of iadademstat plus gilteritinib was safe and showed strong antileukemic activity
Read moreaXess is a restorative arteriovenous dialysis conduit which allows vascular access for hemodialysis through the creation of a new, permanent, living vessel
Read moreEl ensayo analiza un anticuerpo biespecífico frente a la Calreticulina mutada y el CD3 de los linfocitos para frenar estos trastornos hematológicos
Read moreLaminar Pharmaceuticals S.A. se complace en anunciar que el reclutamiento de pacientes para el estudio CLINGLIO (NCT04250922) se ha cerrado después de que 140 pacientes adultos se hayan reclutado con...
Read moreFirst results of two multi-center international Phase 1 dose-escalation and -expansion clinical trials of novel T-cell bispecific antibody cibisatamab as a single agent with or without chemotherapy, a...
Read moreThese are two international clinical trials, LAURA and ADRIATIC, which confirm the positive effect of consolidation with systemic therapies following the combination of chemotherapy in two patient pop...
Read moreEl proyecto contempla un ensayo clínico donde los participantes del mismo sean tratados con dos inmunoterapias conjuntamente tanto antes como después de la extirpación quirúrgica del tumor. Por ot...
Read more